Drug Master Files for: SIBUTRAMINE HYDROCHLORIDE
✉ Email this page to a colleague
SIBUTRAMINE HYDROCHLORIDE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
17171 | I | II | 2/11/2004 | OLON SPA | SIBUTRAMINE HYDROCHLORIDE ANHYDROUS |
17977 | I | II | 1/6/2005 | MYLAN LABORATORIES LTD | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
19729 | I | II | 9/4/2006 | DIVIS LABORATORIES LTD | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
20161 | I | II | 1/17/2007 | CIPLA LTD | SIBUTRAMINE HYDROCHLORIDE |
22373 | I | II | 1/2/2009 | SREENIVASA PHARMA PRIVATE LTD | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
22921 | I | II | 7/1/2009 | SYMED LABS LTD | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information